A small rural district in the most northerly province of Sweden was found to have a very high occurrence of multiple sclerosis. A total of 12 patients with multiple sclerosis among 4744 inhabitants were identified (five females, seven males), corresponding to a prevalence of 253/100 000. Many of the patients were related and a further 21 cases with multiple sclerosis (14 females, seven males), mostly living in the neighbouring area, have family ties to the district. A genealogical investigation showed that 22 of the 33 patients identified had ties of kinship and thus, to our knowledge, the largest aggregation of multiple sclerosis in a family is presented.
Epidemiological and clinical investigations in multiple sclerosis have found a familial aggregation in up to 20% of cases.' 2 The higher concordance rates in monozygotic twins than in dizygotic twins provides strong evidence for a genetically controlled susceptibility to multiple sclerosis.34
When the prevalence of multiple sclerosis exceeds 60 per 100 000 the area is considered to be at high risk, but several countries surveyed show highly significant deviations from homogeneity and the high rate areas tend to be contiguous forming clusters or foci.5 There is a 10-fold difference between regions with the lowest and highest occurrence. Also a number of clusters of unrelated persons have been reported and continue to attract attention although they tend to be anecdotal.68 Clusters of cases in families are a feature of most surveys of multiple sclerosis but many reports9'1 appeared before the era of CSF electrophoresis for the demonstration of oligoclonal bands, and MRI techniques. The studies also rarely describe more than a few cases in the same sibship.
In the present study a large number of patients with multiple sclerosis were found to be living or to have family ties in a small northern Swedish rural district. A high proportion of these patients are related to each other and, to our knowledge, the largest aggregation of multiple sclerosis in a family, is presented.
Patients and methods
The district surveyed is located in the northernmost part of Sweden (fig 1) . It has an area of 2791 km2 and the population on 31 December 1990 was 4744. Most inhabitants live in the small town of Overkalix and the population is ethnically homogeneous.
Local general practitioners had reported a high level of multiple sclerosis in the area and persons with suspected multiple sclerosis in the district were then identified through local physicians and the local multiple sclerosis society.
Multiple sclerosis was defined according to the criteria of Schumacher et al. ' 2 Only cases with clinically definite multiple sclerosis were included. Patients were identified as either relapsing/remitting or primary chronic progressive without remission. Fifty two per cent (17/33) of the patients were examined by one of us (MB). The diagnosis of the remaining patients was confirmed by another specialist experienced in diagnosing multiple sclerosis. Degree of disability was assessed according to the Kurtzke disability status scale. '3 To establish possible kinships in the material an extensive genealogical study was undertaken. Local parish registers were used as well as registers converted into microfiches at the research archives at Umea University, a data base in which the principal sources constitute parish registration material from the 17th up to the end of the 19th century.
The identified cases reported here were either inhabitants of the investigated district on the prevalence day, 31 in this district. By comparison, a pedigree analysis of familial amyloidotic polyneuropathy in another county in northern Sweden showed family ties in 63 out of 127 registered patients with the disease in the region.'4 The high disease prevalence in this population could of course be due to a high frequency of major exogenous risk factors, but no obvious potential environmental factor of importance could be identified. There was no clustering by year of onset as would be expected in the event of a major infectious cause. Furthermore, five of the patients in the pedigree were not even bom in Overkalix and most of the patients were not resident in the district at the time of onset of disease. Thus exposure to exogenous factors has not been uniform and it seems unlikely that environmental factors contribute substantially to the high occurrence of multiple sclerosis in the pedigree.
The pedigree as such does not, however, give us any exact information about the mode of inheritance but it is in agreement with previous studies that exclude simple mendelian (autosomal dominant, autosomal recessive, xlinked recessive) inheritance.'5 Family data in these studies also rule out vertical transmission (mitochondrial or placental) and speculations about a Y-linked resistance gene or parental imprinting also seems unlikely. '5 16 Thus most of the family data available provide evidence for susceptibility to multiple sclerosis being polygenic. '5-17 This too is certainly not contradicted by our pedigree, and the lack of solid evidence of disease in earlier generations makes it difficult to hypothesise different segregation patterns. Recently a Finnish group found linkage to myelin basic protein located on chromosome 18 in 21 families from the county of Osterbotten in the western part of Finland.'8 They proposed an autosomal dominant inheritance with reduced penetrance.
Linkage studies of the family described in this report should also prove to be powerful and through segregation analysis we plan to study how different markers are inherited compared with the heredity of the disease itself. Also the recognition of additional traits that segregate with multiple sclerosis would be of particular interest, as this approach has been successfully exploited for other neurological diseases. Furthermore, identification of clinical phenotypes that cluster within families may delineate subgroups within the familial multiple sclerosis population. The 
